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From the Editor’s Desk
AUSTRALIANS DESERVE 
BETTER THAN THIS
The complexity and chaos of modern health 
care ensure that the system is constantly 
at risk of avoidable errors, which cause 
iatrogenic illness, injury and disability. This 
continuing threat has spawned a variety of 
international responses, driven either by a 
sense of urgency at one end, or by a “softly, 
softly” approach at the other.
The electrifying US report To err is human: 
building a safer health system galvanised public 
opinion with its revelation that 100000 
Americans die each year because of medical 
errors. This seminal report was quickly 
followed by a purposeful blueprint for reform 
— Crossing the quality chasm: a new health 
system for the 21st century.
Similarly, British politicians were recently 
dismayed at the vagueness and bureaucratic 
obfuscation of the National Patient Safety 
Agency in responding to the question of how 
many people die in the United Kingdom from 
medical errors each year. Failure to produce 
this information saw heads roll. The UK’s 
Chief Medical Officer, in ordering a shake-up 
of the services responsible for patient safety, 
demanded that “more needs to be done to 
accelerate the pace of change in this area”.*
Meanwhile, our initial national response — 
the Australian Council for Safety and Quality 
in Health Care of 2000 — has since morphed 
into the Australian Commission on Safety and 
Quality in Health Care in 2006. We have also 
witnessed various safety and quality clones 
appearing in different jurisdictions.
Despite this flurry of seeming activity, 
we are yet to have a clear and concrete 
national enunciation or implementation of 
a comprehensive range of clinically relevant 
workplace safety indicators beyond sentinel 
events, or a timely reporting system for 
mishaps in safety. It appears that our safety 
and quality movement is more comfortable 
to “talk the talk” than “walk the walk”.
Where is our equivalent of the US “100000 
Lives” campaign? Where are our national 
core clinical safety indicators? Where is 
our effective national mandatory incident 
reporting and learning system for safety 
mishaps, or a contemporaneous outcome 
measurement system? Surely Australians 
deserve better than this!
Martin B Van Der Weyden
* Kmietowicz Z. Simplify patient incident reporting, 
says CMO. BMJ 2007; 334: 12.
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Letters
A treatable cause of aborted 
sudden cardiac death
Aditya Kapoor, Timothy A Wells, 
Daniel Wong and John P O’Shea
TO THE EDITOR: Awareness about atypi-
cal and malignant modes of presentation
of a clinical condition can avoid cata-
strophic outcomes, assist in correct diag-
nosis in the appropriate clinical setting
and, as typified by the following case,
offer complete cure.
A 39-year-old woman presented with a 5-
year history of intermittent, recurrent brief
syncopal episodes. During an episode at
presentation, telemetry showed torsade de
pointes with ventricular fibrillation (Box),
and external defibrillation was required to
restore sinus rhythm. Amiodarone infusion
was initiated at a local hospital before the
patient was referred to our institution for
further investigation and management.
On presentation, her heart rate was 50
beats/min and her blood pressure was
170/95 mmHg. No other abnormalities
were detected on examination. A resting
electrocardiogram (ECG) showed prominent
U waves, with a long QT interval (QTc of
540 ms). As the patient had mild hypokalae-
mia (serum potassium level, 3.1 mmol/L),
mild hypocalcaemia (serum calcium level,
2.10 mmol/L) and a prolonged QT interval,
the amiodarone infusion was discontinued,
and supplementation with potassium and
calcium was initiated. In view of the hyper-
tension and hypokalaemia, primary aldos-
teronism was suspected.
Serum cortisol, 24-hour urinary cortisol
and 24-hour urinary catecholamine levels
were normal. The plasma aldosterone/renin
ratio was markedly elevated (1920/1.2=1595;
normal, < 99). Failure of aldosterone sup-
pression after acute saline loading was also
noted. Computed tomography of the abdo-
men showed a right adrenal ovoid mass
(1.9  1.2 cm). Adrenal vein sampling con-
firmed right lateralisation (right to left ratio,
40 : 1; aldosterone level in the right vein was
224000 pmol/L while that in the left vein
was 5570 pmol/L).
Despite initial potassium supplementa-
tion, the hypokalaemia persisted and only
improved after initiating diuretic therapy
with amiloride. Two weeks later, laparo-
scopic right adrenalectomy was performed,
and adrenocortical adenoma was confirmed
histologically. After surgery, plasma aldoster-
one and renin levels normalised to
106 pmol/L and 8.9 mU/L, respectively.
Nine months later, the patient was normo-
tensive (without treatment) and had a nor-
mal ECG with no further recurrence of
arrhythmias.
This was a case of primary aldosteronism
presenting as aborted sudden cardiac death
and malignant syncope secondary to
hypokalaemia-induced torsade de pointes.
Most patients with primary aldosteronism
are either asymptomatic or have symptoms
related to hypertension or hypokalaemia
(eg, polyuria, cramps, paraesthesia or mus-
cle weakness); the diagnosis is often missed
because of the non-specific clinical features.
Primary aldosteronism presenting with car-
diovascular collapse caused by hypokalae-
mic torsade de pointes and recurrent
ventricular fibrillation is extremely rare, as is
presentation as sudden cardiac death sec-
ondary to ventricular fibrillation.1 A pro-
longed QT interval has been reported in
cases of primary aldosteronism,2 with values
normalising after adrenalectomy.3
Aditya Kapoor, Director of Coronary Care
Timothy A Wells, Senior Interventional Fellow
Daniel Wong, Resident Medical Officer
John P O’Shea, Senior Cardiologist
Department of Cardiology, Fremantle Hospital, 
Fremantle, WA.
akapoor65@gmail.com
1 Abdo A, Bebb RA, Wilkins GE. Ventricular fibrilla-
tion: an extreme presentation of primary aldos-
teronism. Can J Cardiol 1999; 15: 347-348.
2 Maule S, Mulatero P, Milan A. QT interval in patients
with primary aldosteronism and low renin hyperten-
sion. J Hypertens 2006; 24: 2459-2464.
3 Matsumura K, Fujii K, Kansui Y, et al. Prolongation of
the QT interval in primary aldosteronism. Clin Exp
Pharmacol Physiol 2005; 32: 66-69. ❏
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LETTERSChildhood overweight and 
obesity by Socio-economic 
Indexes for Areas
Mu Li, Karen Byth and 
Creswell J Eastman
TO THE EDITOR: Childhood overweight
and obesity have become a major public
health concern in Australia. Between July
2003 and December 2004, we conducted
the Australian National Iodine Nutrition
Study (NINS) among schoolchildren.1
While visiting primary schools across Aus-
tralia, we observed that many children were
overweight or obese. The NINS data allowed
us to estimate the prevalence of overweight
and obesity among 8–10-year-old Australian
schoolchildren, and to determine whether
the prevalence was associated with socio-
economic background.
The study population comprised a one-
stage random-cluster sample from all Year 4
school classes in 92 government and non-
government schools.1 Children were aged
8–10 years (mean, 9.3 years). Height and
weight were measured by standard tech-
niques and were used to calculate body
mass index. Overweight and obesity were
identified using international standard defi-
nitions.2 Socioeconomic status was defined
by the Index of Relative Socio-Economic
Advantage/Disadvantage of the Census of
Population and Housing’s Socio-Economic
Indexes for Areas (postal areas).3 This index
is a continuum of advantage to disadvan-
tage. A higher score indicates that an area
has a relatively higher proportion of people
with higher incomes or a skilled workforce.
The prevalence of overweight and obesity
in 8–10-year-old schoolchildren was 18.5%
and 6.5%, respectively. There was no signifi-
cant sex difference in prevalence and no
significant evidence of an association
between socioeconomic status and over-
weight or obesity (Box).
The prevalence of overweight and obes-
ity combined and of obesity alone was
similar to previously reported preva-
lence,4,5 although the age range of the
participants was more limited than in
other studies. We minimised measurement
error bias by using the same equipment
throughout, in the same setting. Further-
more, most measurements were taken by
the same person. We could not demon-
strate an association between socioeco-
nomic status and the prevalence of
overweight and obesity combined, or of
obesity alone. This suggests that childhood
overweight and obesity is common to all
Australian communities, irrespective of
socioeconomic background.
Preventing overweight and obesity in chil-
dren may reduce the risk of adult over-
weight and obesity and related diseases.
Regular monitoring and surveillance of the
situation is needed. Australia is one of the
first countries in the world to develop a
national strategy for overweight and obes-
ity.6 However, the strategy needs to be com-
municated to the wider community and
turned into action to combat this public
health problem.
Acknowledgements: We thank all who contributed
to the Australian National Iodine Nutrition Study.
Mu Li, Senior Lecturer1
Karen Byth, Biostatistician2
Creswell J Eastman, Professor1
1 School of Public Health, University of Sydney, 
Sydney, NSW.
2 Westmead Millennium Institute, Sydney, 
NSW.
muli@health.usyd.edu.au
1 Li M, Eastman CJ, Waite KV, et al. Are Australians
iodine deficient? Results of the Australian National
Iodine Nutrition Study. Med J Aust 2006; 184: 165-169. 
2 Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Estab-
lishing a standard definition for child overweight
and obesity worldwide: international survey. BMJ
2000; 320: 1240-1243.
3 Australian Bureau of Statistics. Information paper.
Census of Population and Housing. Socio-eco-
nomic indexes for areas, Australia, 2001. Can-
berra: ABS, 2003. http://www.ausstats.abs.gov.au/
a u s s t a t s / f re e . n s f / 0 / A F F 5 E 8 5 4 2 B5 8 B9 4 E -
CA256DD5007A3DF8/$File/20390_2001.pdf
(accessed Jan 2007).
4 Booth ML, Wake M, Armstrong T, et al. The epide-
miology of overweight and obesity among Austral-
ian children and adolescents, 1995-1997. Aust N Z J
Public Health 2001; 25: 162-169.
5 Magarey AM, Daniels LA, Boulton TJC. Prevalence
of overweight and obesity in Australian children and
adolescents: reassessment of 1985 and 1995 data
against new standard international definitions. Med
J Aust 2001; 174: 561-564. 
6 Baur LA. Obesity: definitely a growing concern
[editorial]. Med J Aust 2001; 174: 553-554. ❏
Increase in adult body 
weight in coronial autopsies: 
an impending crisis?
Roger W Byard and Maria Bellis
TO THE EDITOR: Obesity in adults
presents significant issues for health care
providers, including practical problems in
transporting and accommodating large
individuals, and in performing standard
tests and investigations.1 However, this
issue has been little addressed in the
mortuary setting, although a recent media
report detailed the need for larger crema-
torium furnaces to accommodate over-
sized coffins, as well as larger graves for
burials.2
We reviewed the body mass index (BMI)
of individuals who had undergone coron-
ial autopsies in South Australia in the first
3 months of 2007. Weight and height of
all bodies were measured using standard-
Proportion (number) of boys and girls categorised as overweight or obese by index of advantage/disadvantage* 
SEIFA 
percentile
Not overweight or obese Overweight Obese 
n Overall Boys Girls Overall Boys Girls Overall Boys Girls
Lowest 10 130 79% (102) 77% (56) 82% (46) 12% (16) 12% (9) 13% (7) 9% (11) 11% (8) 5% (3)
10–25 286 72% (207)  72% (103) 73% (103) 22% (64) 22% (31) 23% (33) 5% (15) 6% (9) 4% (6)
25–50 210 74% (156) 72% (72) 76% (84) 17% (35) 18% (18) 16% (17) 9% (19) 10% (10) 8% (9)
50–75 505 75% (379) 72% (183) 79% (195) 19% (98) 21% (53) 18% (45) 6% (28) 8% (20) 3% (8)
75–90 427 75% (319) 78% (179) 71% (140) 18% (78) 17% (39) 20% (39) 7% (30) 6% (13) 9% (17)
Highest 10 225 77% (174) 79% (84) 76% (89) 17% (39) 16% (17) 19% (22) 5% (12) 6% (6) 5% (6)
Total 1782 75.0% (1337) 74.4% (677) 75.6% (657) 18.5% (330) 18.4% (167) 18.8% (163) 6.5% (115) 7.3% (66) 5.6% (49)
* Overall χ2 = 11.42, P = 0.33; Boys χ2 = 8.73, P = 0.56; Girls χ2 = 12.36, P = 0.26. 
SEIFA = Socio-Economic Indexes for Areas (a higher score corresponds to higher socioeconomic status). ◆MJA • Volume 187 Number 3 • 6 August 2007 195
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BMI by the usual formula.3
A total of 255 individuals aged over 17
years were included in the study (male to
female ratio, 2 : 1; age range, 17–97
years). A third of individuals were classi-
fied as obese (BMI  30 kg/m2), and 6%
as morbidly obese (BMI  40 kg/m2). The
highest BMIs were:
• 132.3 kg/m2 (175 kg, 115 cm);
• 109.0 kg/m2 (315 kg, 170 cm);
• 82.8 kg/m2 (220 kg, 163 cm); and
• 79.5 kg/m2 (201 kg, 159 cm).
In comparison, over a similar time
period at the same institution in 1986,
17% of individuals were obese, and 3%
were morbidly obese, with the four high-
est BMIs being:
• 55.2 kg/m2 (137 kg, 157.5 cm);
• 48.3 kg/m2 (148 kg, 175 cm);
• 44.7 kg/m2 (137 kg, 175 cm); and
• 41.9 kg/m2 (104 kg, 157.5 cm).
This study demonstrates that forensic
facilities are now dealing with individuals
of considerable body mass. Despite gov-
ernment and industry guidelines for man-
ual handling practices,4 these bodies are
difficult to lift, move and store, and
present major logistical problems for
pathologists and technicians attempting to
perform standard examinations. Mechan-
ical lifting hoists, x-ray tables and trolleys
are often not designed to cope with such
weights. Putrefaction is hastened in mor-
bidly obese individuals, and associated
skin slippage and purging makes the bod-
ies even more difficult to handle.
Given that autopsies are often required
in such individuals to determine the
cause of death, consideration must be
given to the significant occupational
health and safety issues they create for
staff in facilities with substandard equip-
ment (ie, designed for normal-sized bod-
ies). The construction of specially
designed mortuaries will be required if
this trend continues, with larger storage
and dissection rooms, and more robust
equipment engineered to cope with
increasing numbers of individuals with
BMIs sometimes considerably greater
than 30 kg/m2. Failure to provide these
may compromise the postmortem evalua-
tion of markedly obese individuals, in
addition to potentially jeopardising the
health of mortuary staff.
Roger W Byard, George Richard Marks 
Professor of Pathology1
Maria Bellis, Laboratory Team Leader2
1 Discipline of Pathology, University of 
Adelaide, Adelaide, SA.
2 Forensic Science SA, Adelaide, SA.
byard.roger@saugov.sa.gov.au
1 Uppot RN, Sahani DV, Hahn PF, et al. Impact of
obesity on medical imaging and image-guided
intervention. AJR Am J Roentgenol 2007; 188:
433-440.
2 Hall L. Super-sized cremators in demand as
nation’s girth all at sea. Sun Herald (Sydney) 2007;
29 Apr.
3 Hensrud DD, Klein S. Extreme obesity: a new
medical crisis in the United States. Mayo Clin
Proc 2006; 81 (10 Suppl): S5-S10.
4 WorkCover Corporation of South Australia. South
Australian Government. Approved Code of Practice
for Manual Handling. September 1990. http://
www.safework.sa.gov.au/contentPages/docs/
resCOPManualHandling.pdf (accessed Jun 2007). ❏
Challenge or opportunity: 
can regional training hospitals 
capitalise on the impending 
influx of interns?
Diann S Eley and David K Morrissey
TO THE EDITOR: The increase in medi-
cal graduates expected over the next
decade presents a huge challenge to the
many stakeholders involved in providing
their prevocational and vocational medi-
cal training.1 Increased numbers will add
significantly to the teaching and supervi-
sion workload for registrars and consult-
ants, while specialist training and access
to advanced training positions may be
compromised. However, this predica-
ment may also provide opportunities for
innovation in the way internships are
delivered.
Although facing these same challenges,
regional and rural hospitals could use this
situation to enhance their workforce by
creating opportunities for interns and jun-
ior doctors to acquire valuable experience
in non-metropolitan settings.
We surveyed a representative sample
(n = 147; 52% of total cohort) of Year 3
Bachelor of Medicine and Bachelor of
Surgery students at the University of
Queensland about their perceptions and
expectations of their impending intern-
ship and the importance of its location (ie,
urban/metropolitan versus regional/rural
teaching hospitals) to their future training
and career plans.
Most students (n = 127; 86%) reported a
high degree of contemplation about their
internship choice. Issues relating to career
progression and support ranked highest in
their expectations. Most perceived intern-
ships in urban/metropolitan hospitals as
more beneficial to their future career pros-
pects compared with regional/rural hospi-
tals, but, interestingly, felt that they would
have more patient responsibility and
greater contact with and supervision by
senior staff in a regional setting (Box).
Regional and rural hospitals should try
to harness these positive perceptions and
act to address any real or perceived short-
comings in order to enhance their future
workforce.2 They could look to establish
partnerships with rural clinical schools3 to
Year 3 medical students’ perceptions of internship in a regional/rural hospital 
versus an urban/metropolitan hospital




disagree Disagree Not sure Agree
Strongly 
agree
My acceptance onto a training program 
will be influenced by the reputation of the 
hospital in which I do my internship
4% (5) 18% (24) 28% (38) 43% (59) 8% (11)
I would have less responsibility for my 
patients in a regional/rural hospital
21% (29) 67% (92) 12% (17) 0 0
There would be more contact with senior 
staff in an urban/metropolitan hospital 
than in a regional/rural hospital
11% (15) 48% (66) 29% (39) 11% (15) 2% (2)
I would have more clinical supervision in 
an urban/metropolitan hospital than in a 
regional/rural hospital
11% (15) 47% (64) 25% (34) 15% (20) 2% (3)
I would feel more part of a team in an 
urban/metropolitan hospital than in a 
regional/rural hospital
11% (15) 60% (83) 27% (38) 2% (3) 0196 MJA • Volume 187 Number 3 • 6 August 2007
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Year 3. To maximise competitiveness with
their urban counterparts, regional and
rural hospitals need to offer innovative
training and career progression pathways
to junior doctors, to combat the percep-
tion that internships in urban hospitals
are more beneficial to future career pros-
pects. Partnerships between hospitals,
medical schools and vocational colleges,
with input from postgraduate medical
cou nc i l s ,  shou ld p rovide  v er t ica l
integration4 in the important period
between student and doctor.
Work is underway to more closely eval-
uate and compare the intern experience
across regional/rural and urban/metropol-
itan hospitals, and track student experi-
ences and career choices longitudinally.
This information may benefit teaching
hospitals and help identify the optimal
combination of resources necessary to
provide quality teaching and a clear career
pathway for the expected influx of new
interns.
Diann S Eley, Senior Research Fellow1
David K Morrissey, Resident Medical Officer2
1 Rural Clinical Division, School of Medicine, 
University of Queensland, Toowoomba, 
QLD.
2 Toowoomba District Health Service, 
Toowoomba, QLD.
d.eley@uq.edu.au
1 Crotty BJ, Brown T. An urgent challenge: new
training opportunities for junior medical officers.
Med J Aust 2007; 186 (7 Suppl): S25-S27. 
2 Eley D, Baker P. Does recruitment lead to reten-
tion? Rural clinical school training experiences
and subsequent intern choices. Rural Remote
He al th  [ In te rne t ]  2 00 6;  6:  5 11 .  h t tp : / /
www.rrh.org.au/articles/showarticlenew.asp?Arti-
cleID=511 (accessed Jun 2007).
3 Australian Government Department of Health
and Ageing. Rural Clinical Schools Program.
h t tp : / / www.h e a lt h .go v.a u /c l i n ic a lsc h o o ls
(accessed Mar 2007).
4 Jolly BC. The new curriculum framework and
assessment practices: current challenges for
postgraduate years 1 and 2. Med J Aust 2007; 186
(7 Suppl): S33-S36. ❏
Intern choices for James Cook 
University graduates
Tarun Sen Gupta, Richard B Hays and 
Richard B Murray
TO THE EDITOR: We report that the
internship location choices of the second
cohort of medical students to graduate
from James Cook University (JCU) are very
similar to those of the first cohort.1 Of the
75 students who graduated in the second
cohort in 2006, 65 (87%) are working in
Queensland; 42 (56%) in North Queens-
land (roughly the area north of Mackay).
Fifty-three (71%) are in non-metropolitan
hospitals, including three of the 10 gradu-
ates who moved or returned interstate.
These proportions reflect the cohort’s
geographic origins. As in the first cohort, a
small number of students (13; 17%) of
North Queensland origin moved away and
a similar number (14; 19%) from elsewhere
stayed in North Queensland. Further, a
majority of the first cohort have remained
where they undertook internship: 24 of 29
(83%) have remained in North Queensland
and one commenced remote practice, con-
sistent with the group’s stated intentions to
work in regional locations.2 Hence, JCU’s
first two graduating cohorts had a com-
bined effect of strong recruitment to non-
metropolitan hospitals, particularly in
Queensland, some of which have experi-
enced difficulty in recruiting junior staff.
These results have two implications.
First, they contribute to the debate on
selection into medicine.3 JCU gives weight
to rural schooling, with about two-thirds of
each cohort having a rural background,
and a similar proportion coming from
North Queensland.4
Second, there are workforce policy
implications. The growth in medical school
numbers over the past 3 years has not
evenly reflected workforce needs or avail-
ability of postgraduate training places. As
some urban areas become oversupplied
with junior doctors, it will be important
not to neglect areas of maldistribution that
are drivers of growth. Regional training
pathways for specialist and generalist
careers need urgent definition; graduates in
Queensland are expected to increase from
300 in 2007 to 727 in 2014, so vocational
training places will need to more than
double.5 An impact on the Australian med-
ical workforce shortage will only be felt
when a number of cohorts have graduated
from JCU and other regional schools, and
bottlenecks to subsequent training are
removed.
It will take another decade to obtain a
clear picture of postgraduate career out-
comes for this group, but the investment in
regional medical education in North
Queensland appears at this stage to be
having the desired effect. If this effect is
sustained and replicated in other new
regional medical schools, Australia may
soon have an adequate supply of medical
graduates who both understand and
choose to live and work in regional Aus-
tralia.
Tarun Sen Gupta, Head, General Practice and 
Rural Medicine1
Richard B Hays, Head2
Richard B Murray, Dean1
1 School of Medicine, James Cook University, 
Townsville, QLD.
2 School of Medicine, Keele University, Keele, 
United Kingdom.
Tarun.Sengupta@jcu.edu.au
1 Hays RB, Wronski I, Veitch J, McCloskey T. Intern
choices for the first graduates of James Cook
University [letter]. Med J Aust 2006; 184: 94. 
2 Veitch C, Underhill A, Hays RB. The career aspira-
tions and location intentions of James Cook Uni-
versity’s first cohort of medical students: a
longitudinal study at course entry and graduation.
Rural Remote Health [Internet] 2006; 6: 537. http://
www.rrh.org.au/articles/showarticlenew.asp?Arti-
cleID=537 (accessed Jun 2007).
3 Van Der Weyden MB. From the Editor’s desk.
Medical student selection — we have to find
another way. Med J Aust 2007; 186: 329. 
4 Hays RB, Bower AJ. Modifying academic ranking
of rural and remote medical school applicants
[letter]. Med J Aust 2001; 174: 371-372.
5 Additional Medical Graduates Project. Medical
education support discussion paper. Brisbane:
Queensland Health, 2007. ❏
Transition Care: what is it 
and what are its outcomes?
Ian D Cameron and Owen Davies
TO THE EDITOR: The Transition Care
Program (TCP) is a joint federal and state
government program that provides short-
term (8–12 weeks) support and therapy to
improve functioning for older people who
are hospitalised (either in public or private
hospitals) and would otherwise require
admission to a residential aged care facil-
ity.1 Participants are provided with a care
package that assists with activities of daily
living, and provides limited allied health,
nursing and medical input, with the aim of
improving functional status, if possible.
The TCP is currently being implemented
across Australia. We selected and audited
three transition care services that com-MJA • Volume 187 Number 3 • 6 August 2007 197
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(2005 and early 2006), with the aim of
describing the outcomes of these services,
and determining whether the older people
participating in the various services were
similar. Approval was obtained from the
relevant ethics committees.
Three services were purposefully sam-
pled: two services in Adelaide (Service A
providing packages in a community set-
ting, and Service B providing packages in a
high-level care, residential aged care set-
ting); and one service in Sydney (Service C
providing packages in a community set-
ting). The residential package allocates
temporary residential placements for
patients with defined rehabilitation goals,
and thus also frees up acute care hospital
beds. These services supplied de-identified
audit data about the first 30 participants,
who were in the program between June and
December 2006.
A summary of the data is given in the
Box. The participants in the residential
program tended to be older, more likely to
be male, and less likely to have “fracture or
fall” as their primary diagnosis. These older
people also had more severe disability that
generally does not improve, and were sig-
nificantly less likely to return to comm-
unity living. The two community-based
programs were generally similar.
The data suggest that there is consider-
able variation between the TCP services,
with the residential service providing pack-
ages to older people with severe disability
who generally remain in a residential aged
care program, although some may improve
from high- to low-level aged care services.
By contrast, the outcome of the comm-
unity-based services is generally mainte-
nance in the community and is associated
with an improvement in functioning. This
profile is similar to that of a community-
based rehabilitation service for older peo-
ple. It is not clear from the TCP guidelines
whether this level of variation in program
implementation was anticipated.1
This limited audit suggests that the Aus-
tralian TCP is not homogeneous and is
substituting for other forms of treatment
and care. Thus, there is provision of high-
level residential care as a substitute for
waiting for residential aged care in a hospi-
tal bed, and community rehabilitation as a
substitute for rehabilitation services pro-
vided by state health departments. This
situation is potentially beneficial to older
people who previously did not have access
to these services, but it also could mean
that state governments may not establish
rehabilitation services for older people, or
may even cease providing these services.
Ian D Cameron, Chair1
Owen Davies, Geriatrician2
1 Rehabilitation Medicine, Rehabilitation 
Studies Unit, Faculty of Medicine, University 
of Sydney, NSW.
2 Aged Care and Rehabilitation, Repatriation 
General Hospital, Adelaide, SA.
ianc@mail.usyd.edu.au
1 Australian Department of Health and Ageing.
Transition Care Program guidelines – 2005. Can-
berra: DHA, 2005. http://www.health.gov.au/inter-
ne t/wcms/publ ishin g.ns f /co nte nt/ age ing-
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Beyond the evidence: 
is there a place for 
antidepressant combinations 
in the pharmacotherapy of 
depression?
David P Horgan
TO THE EDITOR: In an ironic clinician–
academic dichotomy, in the same month
that the Royal Australian and New Zealand
College of Psychiatrists published a survey
showing that 79% of Australian psychia-
trists combine antidepressants and 75% of
psychiatrists believe that general practi-
tioners should be given information on this
topic,1 Keks et al chose a non-psychiatric
journal to “mandate that combinations be
used as a last resort, and only in specialist
settings”.2
Specialists have voted with their pre-
scription pads. That a large majority of
Australian psychiatrists feel ethically and
clinically obliged to use combination anti-
depressants speaks volumes about the poor
results from the suggestions outlined by
Keks et al. The multiple clinical reports and
reviews of the benefits of combination anti-
depressants,3 the suffering and death from
depression, and the very low rate of com-
plications reported to the Adverse Drug
Reactions Advisory Committee from com-
bination antidepressants do not allow the
luxury of awaiting combination therapy
research which may never happen. Many
combinations of antihypertensives or anti-
asthma medications similarly lack such rig-
orous proof, but are widely used. Isolated
case reports of medication complications
must be seen as such.
Access to psychiatrists for combination
antidepressant therapy is a well intentioned
but currently impractical suggestion. Most
psychiatrists have massive waiting lists,
and research confirms treatment resistance
and progressive cell death in the hippo-
campus of depressed patients while await-
ing effective treatment.
Australian GPs are just as capable of
using combination antidepressant therapy
Comparison of background, status and outcomes for participants in three 
Transition Care Program (TCP) services
* Based on a comparison between the three groups (χ2 test for categorical data, and analysis of variance 
[F test] for continuous data). † Patients were in the Program for 12 weeks unless they left early because of 












Mean age (SD) in years 80.9 (7.9) 84.5 (5.1) 80.4 (8.0) ns
Female 60% 47% 59% ns
Living alone 40% 47% 62% ns
Primary diagnosis — 
trauma (fractures and falls)
43% 20% 41% ns
Barthel Index
On admission to the 
TCP — mean (SD)
66.9 (13.8) 55.2 (26.8) 69.2 (19.1) F = 3.85; P = 0.025
On discharge from the 
TCP — mean (SD)
72.8 (17.6) 56.4 (34.2) 82.8 (22.0) F = 7.69; P = 0.001
Mean change (SD) 5.9 (21.3) 1.5 (19.0) 11.6 (13.3) ns
Discharge status 
— in the community†
60% 20% 76% χ2 = 35.6; P = 0.000198 MJA • Volume 187 Number 3 • 6 August 2007
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the same simple information and training.
Canadian GPs read in their journals advice
about using combination antidepressants.
Anecdotally, many Australian GPs combine
antidepressants, but express the wish that
the issue could be discussed openly, with-
out them feeling intimidated. Even text-
books of psychiatry, drafted some years
ago, teach about combination antidepres-
sants. In the United States, the National
Institute of Mental Health STAR*D study of
4000 patients approved combination anti-
depressants such as venlafaxine with mirta-
zapine years ago, with no safety concerns.4
Keks et al refer to treatments that today are
unacceptable to many, ranging from elec-
troconvulsive therapy to tricyclic antide-
pressants, despite GPs and psychiatry
trainees having been warned for years by
academics that tricyclics are outdated,
“dirty” and dangerous.
Informed consent requires that patients be
informed of all therapies that are relevant to
their care and survival, and 88% of psychia-
trists believe patients should be informed of
combination antidepressants.1 Recent results
from the STAR*D study demonstrate the
superiority of modern combination antide-
pressants, with no statistically based evidence
that they should not be used.5
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Murray J Walters, Alston M Unwin and 
Sean B Gills
TO THE EDITOR: Keks et al make a
number of important points about the
place of combination antidepressant strat-
egies in the pharmacotherapy of depres-
sion.1 However, it is important for readers
to note that the vigorous repudiation of
combination treatments is a peculiarly Aus-
tralian preoccupation. Our colleagues in
Europe and North America are not nearly
so troubled.
Combination antidepressant treatments
are widely used by specialists. A recent
survey of Australian doctors working in
psychiatry reported that 79% of respond-
ents had used combination antidepressants
and that 75% believed that general practi-
tioners should be given information on
their use.2
There is emerging evidence for the use of
combination antidepressant strategies —
from case series, open clinical trials, and
randomised controlled trials (RCTs). The
largest summation of the data is a meta-
analysis which found that combination
antidepressant treatment produced a 62%
response rate when monotherapy had
failed.3 Although this finding alone cannot
be convincing because of the acknow-
ledged lack of large sample RCTs, it is quite
another matter to decry combination pre-
scribing as clinically unsound based only
on the history of augmentation treatments
such as lithium and, to a lesser extent,
thyroid hormone treatment when, anecdo-
tally, they provide such clinically disap-
pointing results.
It is not unreasonable to assert the pri-
macy of good clinical reasoning, including
sensible prescribing of combination antide-
pressants, over rigid adherence to evi-
denced-based algorithms. This sort of
thinking is allowable because the evidence
base for the treatment of depression is
poor. Meaningful guidelines cannot be pro-
duced while the evidence is predicated on
the flawed proposition that depression is
an “it” (a homogenous construct).4
GPs might well be puzzled by the zeal in
academic psychiatry for monotherapy.
They are advised to “optimise” mono-
therapy, but not told what this means. They
are very familiar with models of staged
polypharmacy for common chronic ill-
nesses such as hypertension, epilepsy, dia-
betes, and asthma, but in psychiatric
pharmacotherapy this is apparently unwise
or too risky.
The way such admonishments are usu-
ally framed is by reference to serious but
rare adverse reactions (like the serotonin
syndrome), without proper attention to the
equally serious and probably more com-
mon problems with the current “simple”
psychotropic drug options already used by
GPs. Failure to contextualise these risks
leads to a distortion of risk–benefit pre-
scribing decisions and an unnecessary
restriction of treatment choices.
We must have a commonsense approach
to the treatment of depression that recog-
nises the proper context of our knowledge
base. Combination antidepressant treat-
ments may be “beyond the evidence”, but
this alone is not a sufficient justification to
stop using them.
Murray J Walters, Psychiatrist1
Alston M Unwin, Psychiatrist2
Sean B Gills, Psychiatrist1
1 The Pinel Clinic, Brisbane, QLD.
2 The Connelly Clinic, Brisbane, QLD.
murray.walter@healthecare.com.au
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Nicholas A Keks, Graham D Burrows, 
David L Copolov, Richard Newton, 
Nick Paoletti, Isaac Schweitzer and 
John W G Tiller
IN REPLY: The letters by Horgan and
Walters et al underline our motive for
reviewing antidepressant combinations.
The conclusions of the survey are at least
questionable, given that the response rate
was only 36%, 18% of respondents were
not psychiatrists, and affirmative respond-
ers may have only used combination anti-
depressants once.1 In any case, should
clinical popularity substitute for evidence?
If so, once popular but now research-
discredited treatments such as insulin
coma therapy would still be used.
Equating combination antidepressants to
combination drugs for asthma and hyper-
tension is misleading. How often are two β-
blockers given together in maintenance
treatment? Major depression causes severe
suffering, but this does not justify the use
of unproven treatments ahead of those
supported by evidence.
General  prac ti t ioners  should be
informed about antidepressant combina-
tions, but the information must be evi-
dence-based. We described the process of
dose optimisation, and stand by our advice
that complex cases that require unprovenMJA • Volume 187 Number 3 • 6 August 2007 199
LETTERSLETTERStreatment (such as combination antidepres-
sants) be referred to a psychiatrist.
Patients should also be informed about
combination antidepressants, including the
paucity of evidence concerning efficacy and
safety, the absence of information about
consequences of long-term treatment, and
that some combinations are lethal and oth-
ers frequently unsafe.
Published data from the STAR*D study
provide equivocal support for the combina-
tion of citalopram and bupropion, as we
noted. Evidence of modest effectiveness
(remission rate, 13.7%) for the combina-
tion of mirtazapine and venlafaxine has
appeared.2
Our conclusion was that some antide-
pressant combinations could be used in
certain clinical situations where evidence-
based treatments have failed, with safe-
guards. Given that 17% of respondents to
the survey1 observed serious complications
with combination antidepressants, this is
good advice.
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Writing to the next of kin 
after the death of a patient
Ian T Jones
TO THE EDITOR: In his “Personal per-
spective” piece, Allen1 reminded us all of
how medicine can at times truly be the
noblest of professions. Writing to the
next of kin after the death of a patient is
occasionally a difficult task, but more
usually provides an appropriate form of
closure, not only to the relationship with
the deceased patient, but also to relation-
ships with the person’s partner, family
members and friends whom you may
have met during the treatment episode
and whom you may not see again.
Since I began practice as a consultant
20 years ago (a practice that involves a
substantial number of patients who
require surgery for cancer), I have tried
to write to the next of kin or significant
other of every patient who has died while
under my care.
The letter allows me the opportunity to
say perhaps how brave the patient had
been in the face of adversity or to
acknowledge the support the next of kin
had provided. A simple expression of
condolence and an indication of how
much a loved one may be missed seems
to be the best way to “sign off”.
Such letters are only a small gesture,
but I have often been gratified by how
much comfort they seem to provide to
those who receive them, and in all this
time I have never had a response that
could even remotely be considered “neg-
ative”.
In this current day, when practising
clinicians appear to have a diminished
role in our medical schools, may I sug-
gest that Allen’s article — which I think is
a great example of what is meant by the
“art of medicine” — be distributed to our
universities and colleges to be considered
for inclusion in their teaching material
and curricula.
Ian T Jones, Head
Colorectal Surgery Unit, Private Medical 
Centre, Royal Melbourne Hospital, 
Melbourne, VIC.
itjones@bigpond.net.au
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